Cargando…
Targeted next generation sequencing of circulating tumor DNA provides prognostic information for management in breast cancer patients
BACKGROUND: Circulating tumor DNA (ctDNA) is a non-invasive biomarker for evaluating cancer prognosis. The aim of this study was to analyze the genomic profile of circulating tumor DNA (ctDNA) in breast cancer patients, and evaluate its clinical implications. METHODS: Targeted sequencing of ctDNA wa...
Autores principales: | Shim, Hyoeun, Kwon, Min Jeong, Park, In Hae, Kim, Min Kyeong, Cho, Eun-Hae, Lee, Junnam, Lee, Seung-Tae, Sim, Sung Hoon, Lee, Keun Seok, Kim, Yun-Hee, Kim, Seok-Ki, Lee, Eun Sook, Kong, Sun-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848433/ https://www.ncbi.nlm.nih.gov/pubmed/35282050 http://dx.doi.org/10.21037/atm-21-4881 |
Ejemplares similares
-
Development and performance evaluation of an artificial intelligence algorithm using cell-free DNA fragment distance for non-invasive prenatal testing (aiD-NIPT)
por: Lee, Junnam, et al.
Publicado: (2022) -
Identification of a Novel De Novo Variant in the PAX3 Gene in Waardenburg Syndrome by Diagnostic Exome Sequencing: The First Molecular Diagnosis in Korea
por: Jang, Mi-Ae, et al.
Publicado: (2015) -
Phase I/II clinical trial of everolimus combined with gemcitabine/cisplatin for metastatic triple-negative breast cancer
por: Park, In Hae, et al.
Publicado: (2018) -
Integrative In Vivo Drug Testing Using Gene Expression Signature and Patient-Derived Xenografts from Treatment-Refractory HER2 Positive and Triple-Negative Subtypes of Breast Cancer
por: Ryu, Jin-Sun, et al.
Publicado: (2019) -
Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib
por: Oh, Chung Ryul, et al.
Publicado: (2019)